<DOC>
	<DOCNO>NCT00249483</DOCNO>
	<brief_summary>Preliminary research show venlafaxine , medication currently use treat depression , may also discourage cocaine use depressed individual . This study evaluate effectiveness venlafaxine reduce cocaine use alleviate depression individual addict cocaine .</brief_summary>
	<brief_title>Venlafaxine Reduce Cocaine Dependence Depressed Individuals</brief_title>
	<detailed_description>Individuals addict cocaine often experience feeling restlessness , irritability , anxiety . They also often report feel depress use cocaine , tend resume cocaine use alleviate symptom depression . Venlafaxine medication currently use treat depression anxiety disorder . Preliminary research show venlafaxine reduces depression , improve mood , simultaneously reduce cocaine use cocaine addict . Further research need confirm benefit venlafaxine cocaine addict . The purpose study evaluate effectiveness venlafaxine reduce cocaine use , cocaine craving , depression individual addict cocaine diagnose depression . This study begin 1-week lead-in phase , participant receive placebo medication . Participants whose depression level decrease continue treatment phase study , eligible cocaine relapse therapy medication deem necessary treating psychiatrist . Participants remain depressed follow lead-in phase randomly assign receive either venlafaxine placebo 12 week . Participants assign venlafaxine initially receive daily dose 37.5 mg. After 4 day , dose increase 75 mg ; week thereafter , dose increase another 75 mg , maximum 300 mg per day , dependent side effect positive response . Study visit take place twice week . At visit , medication side effect depression level assess , cocaine level monitor urine test , self-reports complete . Blood drawn per month laboratory test . Participants also attend therapy session week , meet psychiatrist every week assessment . Participants show decrease depression 12 week treatment continue additional 12 week monitor cocaine use depression level .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Meets DSMIV diagnosis criterion current cocaine dependence Used cocaine least one day month prior study entry Meets DSMIV criterion major depression dysthymia , depression either primary ( predate early lifetime substance abuse ) , depression persistent 6 month cocaine abstinence past , depression least 3 month prior study entry If female , willing use contraception throughout study Meets DSMIV diagnosis criterion bipolar disorder , schizophrenia , psychotic disorder transient psychosis due drug abuse Chronic organic mental disorder Significant risk suicide , base current mental state history Untreated seizure disorder history substancerelated seizure Unstable physical disorder may make study participation dangerous , include hypertension , hepatitis ( mildly elevate transaminase level less 4 time upper limit normal level acceptable ) , diabetes Coronary vascular disease , indicate medical history , suspect abnormal ECG , history heart symptoms Irregular heartbeat indicate QRS duration great 0.11 Current use prescribe psychotropic medication Currently meet DSMIV diagnosis criterion dependence drug nicotine , marijuana , alcohol History allergic adverse reaction desipramine venlafaxine Prior history fail respond venlafaxine History alcohol withdrawal syndrome year prior study entry Current evidence alcohol withdrawal , pulse rate great 115 beat per minute , blood pressure great 140/90 mm Hg , visible tremor Pregnant breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Cocaine Addiction</keyword>
	<keyword>Cocaine Dependence</keyword>
</DOC>